![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
Novelty: 17β-Aminobenzoyl-4-aza-5α-androst-1-en-3-ones and related compounds are claimed for the treatment of hyperandrogenic conditions including prostatic hypertrophy.
Biology: No biological data are presented.
Chemistry: Six compounds are specifically claimed including 17β(4-dimethylaminophenyl-carbonyl)-4-aza-5α-androst-1-en-3-one; synthesis from a steroid ester is described.
Structure:
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.